Northern Trust’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-16,955
| Closed | -$2.01M | – | 4693 |
|
|
2021
Q1 | $2.01M | Sell |
16,955
-11,903
| -41% | -$1.41M | ﹤0.01% | 3243 |
|
|
2020
Q4 | $3.41M | Sell |
28,858
-2,420
| -8% | -$281K | ﹤0.01% | 2896 |
|
|
2020
Q3 | $3.48M | Sell |
31,278
-2,035
| -6% | -$219K | ﹤0.01% | 2754 |
|
|
2020
Q2 | $3.4M | Sell |
33,313
-5,119
| -13% | -$548K | ﹤0.01% | 2755 |
|
|
2020
Q1 | $4.15M | Sell |
38,432
-110
| -0.3% | -$12.6K | ﹤0.01% | 2412 |
|
|
2019
Q4 | $4.49M | Sell |
38,542
-524
| -1% | -$60.7K | ﹤0.01% | 2648 |
|
|
2019
Q3 | $4.47M | Buy |
39,066
+5,714
| +17% | +$568K | ﹤0.01% | 2611 |
|
|
2019
Q2 | $3.18M | Sell |
33,352
-78
| -0.2% | -$7.35K | ﹤0.01% | 2803 |
|
|
2019
Q1 | $3.05M | Sell |
33,430
-3,910
| -10% | -$320K | ﹤0.01% | 2834 |
|
|
2018
Q4 | $2.83M | Sell |
37,340
-866
| -2% | -$63.7K | ﹤0.01% | 2858 |
|
|
2018
Q3 | $3.06M | Buy |
38,206
+2,206
| +6% | +$206K | ﹤0.01% | 2974 |
|
|
2018
Q2 | $3.58M | Buy |
36,000
+27,806
| +339% | +$2.4M | ﹤0.01% | 2871 |
|
|
2018
Q1 | $663K | Buy |
8,194
+200
| +3% | +$16.2K | ﹤0.01% | 3496 |
|
|
2017
Q4 | $630K | Buy |
7,994
+385
| +5% | +$32K | ﹤0.01% | 3506 |
|
|
2017
Q3 | $702K | Buy |
7,609
+4,309
| +131% | +$414K | ﹤0.01% | 3518 |
|
|
2017
Q2 | $373K | Sell |
3,300
-3,900
| -54% | -$436K | ﹤0.01% | 3639 |
|
|
2017
Q1 | $721K | Buy |
7,200
+200
| +3% | +$21.4K | ﹤0.01% | 3442 |
|
|
2016
Q4 | $753K | Hold |
7,000
| – | – | ﹤0.01% | 3425 |
|
|
2016
Q3 | $872K | Hold |
7,000
| – | – | ﹤0.01% | 3383 |
|
|
2016
Q2 | $744K | Buy |
+7,000
| New | +$813K | ﹤0.01% | 3421 |
|
Northern Trust's CBPO Position: Q2 2021 in Review
Northern Trust sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 16,955 shares — an estimated $2.01M sold.
Northern Trust first reported a position in CBPO in Q2 2016 and held it in 20 quarters. The position peaked at $4.49M in Q4 2019. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Northern Trust reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Northern Trust sold 16,955 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $2.01M.
- Northern Trust first reported a position in China Biologic Products Holdings, Inc. in Q2 2016 and held it in 20 quarters.
- Northern Trust's China Biologic Products Holdings, Inc. position peaked at $4.49M in Q4 2019.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Northern Trust's 13F filing for Q2 2021, filed 13 Aug 2021.